Shikonin Inhibits Thyroid Cancer Cell Growth and Invasiveness through Targeting Major Signaling Pathways.

Conclusion:We for the first time demonstrated that shikonin is a potentially effective antitumor agent for thyroid cancers.
PMID: 24106286 [PubMed - as supplied by publisher]

Source: Clinical Breast Cancer - October 8, 2013 Category: Cancer & Oncology Authors: Yang Q, Ji M, Guan H, Shi B, Hou P Tags: J Clin Endocrinol Metab Source Type: research